Replies to post #322480 on NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

True...but yet the UK clinical trial site listed and confirmed the change, right? Given the changes in the FDA guidelines and the UK change, I think it is reasonable to suspect the same in all of the regulatory agencies. By the way, didn't Bosch relocate to Germany?

The FDA does not make the decision. They advise the company only.

When it comes time to actually evaluate a BLA, then the FDA will decide what they think of such an endpoint change.

NWBO has never said anything on the change. Nor have we seen the update on either clinical trials gov or the German site.